Searched for
BIOSIMILAR AVT03
Dr. Reddy’s Laboratories shares jump over 1% as European Commission approves biosimilar AVT03Dr. Reddy's Laboratories secured European Commission approval for AVT03, a biosimilar to Prolia and Xgeva, for osteoporosis and bone compli...- Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across EuropeDr. Reddy's Laboratories has secured European Commission marketing approval for AVT03, a biosimilar to Prolia and Xgeva, used for bone-rela...
- Dr Reddy's gets European nod for biosimilar to treat osteoporosisProlia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk ...
- Alvotech, Dr. Reddy's ink pact for commercialisation of denosumabAlvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreem...
Load More